Tuğçe Yavuz Mollavelioğlu

Tuğçe Yavuz Mollavelioğlu

Auto-generated profile, based on publicly available information

Tuğçe Yavuz Mollavelioğlu

Department of Physical Medicine and Rehabilitation, Division of Pain Medicine, Gaziosmanpaşa Training and Research Hospital, Istanbul, Türkiye

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2026 in Pain Research and Management
Verified
Journal Article
Open access
PDF file
MSMevlüt Gökhan Sucu
Mevlüt Gökhan Sucu
TMTuğçe Yavuz Mollavelioğlu
Tuğçe Yavuz Mollavelioğlu
AYAyşegül Akyüz Yildirim
Ayşegül Akyüz Yildirim
NÇNalan Çelebi
Nalan Çelebi
Background: Intravenous ketamine and lidocaine infusions are increasingly used for chronic peripheral neuropathic pain, particularly in refractory cases. However, comparative data on their short‐ and midterm analgesic outcomes in routine clinical practice are limited. Methods: This retrospective study included patients with chronic peripheral neuropathic pain who received intravenous ketamine or lidocaine infusion between January and May 2021. Ketamine was administered at 1 mg/kg/h and lidocaine at 3 mg/kg/h for five consecutive days. Pain intensity and neuropathic pain features were assessed using the Numeric Rating Scale (NRS) and the Douleur Neuropathique 4 (DN4) questionnaire at baseline and at 2 weeks, 2 months, and 6 months after treatment. Clinically meaningful pain relief was defined as a ≥ 50% reduction in pain scores. Results: A total of 102 patients were analyzed (ketamine group, n = 44; lidocaine group, n = 58). Both groups showed significant reductions in NRS and DN4 scores at all follow‐up points compared with baseline ( p < 0.01). Clinically meaningful pain relief was more frequent in the ketamine group at 2 weeks ( p < 0.01), whereas no significant differences were observed at 2 and 6 months ( p > 0.05). Adverse effects occurred more often with ketamine, while lidocaine was associated with fewer side effects ( p < 0.05). Conclusion: Ketamine provided a greater early analgesic response at 2 weeks, whereas both treatments demonstrated comparable midterm efficacy at 2 and 6 months. Trial Registration: ClinicalTrials.gov identifier: NCT06297915

1 January 2025 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
TMTuğçe Yavuz Mollavelioğlu
Tuğçe Yavuz Mollavelioğlu
NPNURDAN PAKER
NURDAN PAKER
IKIlhan Karacan
Ilhan Karacan
Gursel ÖzçakarGursel Özçakar
Gursel Özçakar
Objective: The goal of this study was to measure femoral cartilage thickness in patients with symptomatic joint hypermobility (SJH) using ultrasound (US) imaging. Methods: This cross‐sectional study comprised 42 female patients diagnosed with SJH (Beighton score > 3) and 42 age‐matched healthy controls. Ultrasonographic measurements of bilateral femoral cartilage thickness were conducted in three areas: medial, intercondylar, and lateral, while the patients were in a supine position with their knees fully flexed. The Numeric Pain Rating Scale and the Turkish version of the Knee Injury and Osteoarthritis Outcome Score were used to evaluate pain and functional status in the SJH group. Results: The mean age was 28.0 ± 7.1 years in the study group and 28.5 ± 7.2 years in the control group. The right medial, left medial, left intercondylar, and left lateral femoral cartilage thicknesses of patients in the SJH group were significantly thinner than those of patients in the control group ( p < 0.05). There was no significant difference in femoral cartilage thickness, pain, and functional scores between patients with and without knee hypermobility within the SJH group ( p > 0.05). A negative correlation was observed between femoral cartilage thickness and age, which was identified as an independent predictor of femoral cartilage thickness in SJH ( p < 0.05). Conclusion: Femoral cartilage thickness was significantly reduced on the right/left medial, left intercondylar, and left lateral sides in women with SJH compared to healthy subjects. Furthermore, age appears to be an important determinant of femoral cartilage thickness.

30 October 2026 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
EAEbru Alanbay-Yagci
Ebru Alanbay-Yagci
TMTuğçe Yavuz Mollavelioğlu
Tuğçe Yavuz Mollavelioğlu
Background: Large language models (LLMs) are increasingly used by patients and clinicians to obtain health-related information, yet their reliability in neck pain and interventional pain management remains uncertain. This study compared ChatGPT-5.2 and Gemini 3 Pro using a multidimensional, short-term repeated-assessment framework evaluating clinical performance, safety, readability, expert assessment, and temporal consistency. Methods: A standardized, investigator-developed set of 50 neck pain-related questions included patient-oriented questions, interventional pain management, safety and red-flag scenarios, and clinical vignettes. The same questions were submitted to both models at Week 0 and Week 2, with one response obtained for each model–question–time-point combination. Responses were anonymized, and evaluators were blinded to model identity. Accuracy, completeness, usefulness, and guideline adherence were assessed using predefined 5-point ordinal Likert-type scales, while red-flag omission, hallucinated facts, and overconfident inappropriate recommendations were evaluated as binary outcomes. Readability was assessed for patient-oriented questions, and reviewer comment scores were independently assigned by two evaluators. Analyses were exploratory, with no formal adjustment for multiple comparisons; p-values < 0.05 were considered nominally statistically significant. Results: Two hundred responses were evaluated. At Week 0, Gemini had higher completeness and usefulness scores, whereas no nominally significant between-model differences were observed for accuracy or guideline adherence. At Week 2, ChatGPT had higher completeness scores, whereas Gemini had higher guideline adherence and usefulness scores; no nominally significant difference was observed for accuracy. Reviewer comment scores were lower for Gemini at both time points. Several within-model between-time-point differences were nominally significant but were interpreted as short-term variation rather than evidence of true longitudinal change. No nominally significant between-model differences were observed in the interventional pain management subgroup. Red-flag omissions were more frequent with ChatGPT than Gemini at Week 0 (24% vs. 8%; p = 0.008), whereas no nominally significant between-model difference was observed at Week 2. No nominally significant between-model differences were observed for hallucinated facts or overconfident inappropriate recommendations. ChatGPT had higher Flesch–Kincaid Grade Level scores at both time points, indicating greater textual complexity. Inter-rater reliability for reviewer comment scores ranged from good to excellent. Conclusions: ChatGPT-5.2 and Gemini 3 Pro generally received high scores within the predefined evaluation framework, but between-model differences varied by outcome and assessment time point and did not consistently favor either model. Differences between Week 0 and Week 2 should be interpreted as short-term variation in observed model output rather than evidence of true improvement or deterioration. These findings support multidimensional, time-specific evaluation of LLMs. LLMs should be regarded as informational or decision-support tools rather than substitutes for professional clinical reasoning or individualized clinical decision-making, particularly in safety-critical or interventional contexts.

27 October 2023 in Anatolian Current Medical Journal
Verified
Journal Article
Open access
PDF file
EGEmel Güler
Emel Güler
MPMusa Polat
Musa Polat
GSGülay Soykök
Gülay Soykök
TMTuğçe YAVUZ MOLLAVELİOĞLU
Tuğçe YAVUZ MOLLAVELİOĞLU
Aims: Expression of carpal tunnel syndrome (CTS) caused by the entrapped median nerve includes pain, paraesthesia and numbness. Extra median spread of pain can furthermore be seen as a clinical requirement defined by neuro inflammation. Central sensitization (CS) constructs a similar mechanism. This study aims to evaluate sensitization in patients diagnosed with CTS. Methods: A total number of 152 patients diagnosed with CTS were evaluated, prospectively. Patients data such as gender, age, body mass index (BMI), disease duration, pain severity (NRS), painDETECT questionnaire, Boston CTS symptom severity scale (SSS) and functional status scale (FSS), CS scale, electroneuromyography results have been collected by the author and then the patients are divided into three groups. Results: Regarding the age, BMI and CS rate, there was no statistical difference between the three patient groups (p>0.05). However, a statistically significant difference was found between these groups in disease duration, day-time and night-time NRS, Boston SSS, FSS, and pain DETECT scores (p 0.05). Yet, statistically significant differences were found in a comparison of the patients with and without CS, in disease duration, NRS night scores, and painDETECT scores (p<0.05). Conclusion: We conclude that the rate of CS is often undervalued in patients with CTS. CS should be considered in CTS patients with extra-median spread of pain.